Philips Healthcare and Spectranetics Corp. announced they have entered into a definitive merger agreement for $2.05 billion. The acquisition of Spectranetics will further expand and strengthen...
Drug-Eluting Balloons
-
-
C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint to a six-month time...
-
New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the durability, consistency and safety of Medtronic’s IN.PACT Admiral drug-coated balloon. The...
-
Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT Admiral drug-coated balloon (DCB) as a treatment for in-stent restenosis (ISR) in patients with...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study...
News | Drug-Eluting Balloons | April 26, 2017
April 26, 2017 — Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA...
News | Peripheral Arterial Disease (PAD) | March 09, 2017
March 9, 2017 — Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a...
News | Drug-Eluting Balloons | February 08, 2017
February 8, 2017 — Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food...
News | Drug-Eluting Balloons | December 06, 2016
December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch...
Technology | Drug-Eluting Balloons | September 26, 2016
September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an...
News | Drug-Eluting Balloons | September 22, 2016
September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...
Technology | Drug-Eluting Balloons | September 19, 2016
September 19, 2016 — Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT...
Feature | Cath Lab | September 14, 2016
Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular...
Technology | Drug-Eluting Balloons | July 18, 2016
July 18, 2016 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral...
News | Drug-Eluting Balloons | June 03, 2016
June 3, 2016 — Cardionovum GmbH recently announced the completion of enrollment of the RAPID trial. Results will be...
The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.
Feature | Peripheral Arterial Disease (PAD) | February 22, 2016 | Dave Fornell
It is estimated that more than 10 million people in the United States are affected by...
News | Drug-Eluting Balloons | January 18, 2016
January 18, 2016 — Medtronic plc announced that the IN.PACT Admiral ...
Image courtesy of Medtronic
Feature | Drug-Eluting Balloons | October 22, 2015
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a...
